EGFR and neoplasm: In particular, integrins are known to mediate cell-ECM interactions and have been shown to play important roles in tumor progression, metastasis, anoikis resistance, and chemotherapy resistance through activation of downstream pathways such as the EGFR–AKT pathway [24,25,26,27,28,30,32].